Grant Grady III — SEC Form 4 filings

SEC reporting owner CIK 1679966. 6 Form 4 filings on record with FilingPulse; latest filed 2026-08-10.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-06-03 to 2026-08-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Aptevo Therapeutics Inc. (APVO)Director61 leg · 13,513 sh · $20,13410

Form 4 filings — Grant Grady III

FiledFormIssuerReported transactionsSource
2026-08-104Aptevo Therapeutics Inc. (APVO)Option exercise (M): 400 · Option exercise (M): 400 (derivative) @ $0EDGAR
2025-11-124Aptevo Therapeutics Inc. (APVO)Purchase (P): 13,513 @ $1.49EDGAR
2025-08-084Aptevo Therapeutics Inc. (APVO)Grant/award (A): 7,200 (derivative) @ $0EDGAR
2025-07-214Aptevo Therapeutics Inc. (APVO)Option exercise (M): 1 · Option exercise (M): 1 (derivative) @ $0EDGAR
2024-07-194Aptevo Therapeutics Inc. (APVO)Grant/award (A): 925 (derivative) @ $0EDGAR
2024-06-034Aptevo Therapeutics Inc. (APVO)Option exercise (M): 7 · Option exercise (M): 81 · Option exercise (M): 7 (derivative) @ $0 · Option exercise (M): 81 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1679966 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →